Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells

Fluids and Barriers of the CNS

Danica B Stanimirovic¹  Jagdeep K Sandhu¹  Caroline Sodja¹  Tammy-Lynn Tremblay¹  Christie E Delaney¹  Arsalan S Haqqani¹ 

[1] National Research Council of Canada, Human Health Therapeutics Portfolio, 100 Sussex Drive, Ottawa, ON, K1A 0R6, Canada

关键词: Receptor-mediated transcytosis;    Biomarkers;    CNS;    Endothelial cells;    Microvesicles;    Mass spectrometry;    Drug delivery;    Blood–brain barrier;    Proteomics;    Exosomes;   

Others  :  807033
DOI  :  10.1186/2045-8118-10-4

 received in 2012-09-21, accepted in 2012-12-18,  发布年份 2013

【 摘 要 】

Background

In addition to possessing intracellular vesicles, eukaryotic cells also produce extracellular microvesicles, ranging from 50 to 1000 nm in diameter that are released or shed into the microenvironment under physiological and pathological conditions. These membranous extracellular organelles include both exosomes (originating from internal vesicles of endosomes) and ectosomes (originating from direct budding/shedding of plasma membranes). Extracellular microvesicles contain cell-specific collections of proteins, glycoproteins, lipids, nucleic acids and other molecules. These vesicles play important roles in intercellular communication by acting as carrier for essential cell-specific information to target cells. Endothelial cells in the brain form the blood–brain barrier, a specialized interface between the blood and the brain that tightly controls traffic of nutrients and macromolecules between two compartments and interacts closely with other cells forming the neurovascular unit. Therefore, brain endothelial cell extracellular microvesicles could potentially play important roles in ‘externalizing’ brain-specific biomarkers into the blood stream during pathological conditions, in transcytosis of blood-borne molecules into the brain, and in cell-cell communication within the neurovascular unit.

Methods

To study cell-specific molecular make-up and functions of brain endothelial cell exosomes, methods for isolation of extracellular microvesicles using mass spectrometry-compatible protocols and the characterization of their signature profiles using mass spectrometry -based proteomics were developed.

Results

A total of 1179 proteins were identified in the isolated extracellular microvesicles from brain endothelial cells. The microvesicles were validated by identification of almost 60 known markers, including Alix, TSG101 and the tetraspanin proteins CD81 and CD9. The surface proteins on isolated microvesicles could potentially interact with both primary astrocytes and cortical neurons, as cell-cell communication vesicles. Finally, brain endothelial cell extracellular microvesicles were shown to contain several receptors previously shown to carry macromolecules across the blood brain barrier, including transferrin receptor, insulin receptor, LRPs, LDL and TMEM30A.

Conclusions

The methods described here permit identification of the molecular signatures for brain endothelial cell-specific extracellular microvesicles under various biological conditions. In addition to being a potential source of useful biomarkers, these vesicles contain potentially novel receptors known for delivering molecules across the blood–brain barrier.

【 授权许可】

   
2013 Haqqani et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 3.

Figure 6.

【 参考文献 】

• [1]Begley DJ, Brightman MW: Structural and functional aspects of the blood–brain barrier. Prog Drug Res 2003, 61:39-78.
• [2]Pardridge WM, Buciak JL, Friden PM: Selective transport of an anti-transferrin receptor antibody through the blood–brain barrier in vivo. J Pharmacol Exp Ther 1991, 259:66-70.
• [3]Yu YJ, Zhang Y, Kenrick M, Hoyte K, Luk W, Lu Y, Atwal J, Elliott JM, Prabhu S, Watts RJ, Dennis MS: Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med 2011, 3:84ra44.
• [4]Coloma MJ, Lee HJ, Kurihara A, Landaw EM, Boado RJ, Morrison SL, Pardridge WM: Transport across the primate blood–brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res 2000, 17:266-274.
• [5]Boado RJ, Hui EK, Lu JZ, Zhou QH, Pardridge WM: Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein. J Biotechnol 2010, 146:84-91.
• [6]Demeule M, Currie JC, Bertrand Y, Che C, Nguyen T, Regina A, Gabathuler R, Castaigne JP, Beliveau R: Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 2008, 106:1534-1544.
• [7]Gabathuler R: Development of new peptide vectors for the transport of therapeutic across the blood–brain barrier. Ther Deliv 2010, 1:571-586.
• [8]Ohshima-Hosoyama S, Hosoyama T, Nelon LD, Keller C: IGF-1 receptor inhibition by picropodophyllin in medulloblastoma. Biochem Biophys Res Commun 2010, 399:727-732.
• [9]Yang C, Robbins PD: The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011, 2011:842849.
• [10]Thery C: Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep 2011, 3:15.
• [11]Cocucci E, Racchetti G, Meldolesi J: Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19:43-51.
• [12]Pant S, Hilton H, Burczynski ME: The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 2012, 83:1484-1494.
• [13]Thery C, Amigorena S, Raposo G, Clayton A: Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006, 3:22.
• [14]Simpson RJ, Jensen SS, Lim JW: Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8:4083-4099.
• [15]Mathivanan S, Fahner CJ, Reid GE, Simpson RJ: ExoCarta 2012: database of exosomal proteins. RNA and lipids. Nucleic Acids Res 2012, 40:D1241-D1244.
• [16]Smalheiser NR: Do Neural Cells Communicate with Endothelial Cells via Secretory Exosomes and Microvesicles? Cardiovasc Psychiatry Neurol 2009, 2009:383086.
• [17]Vella LJ, Sharples RA, Nisbet RM, Cappai R, Hill AF: The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur Biophys J 2008, 37:323-332.
• [18]Segura E, Amigorena S, Thery C: Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis 2005, 35:89-93.
• [19]Liu ML, Williams KJ: Microvesicles: potential markers and mediators of endothelial dysfunction. Curr Opin Endocrinol Diabetes Obes 2012, 19:121-127.
• [20]Virgintino D, Rizzi M, Errede M, Strippoli M, Girolamo F, Bertossi M, Roncali L: Plasma membrane-derived microvesicles released from tip endothelial cells during vascular sprouting. Angiogenesis 2012, 15:761-769.
• [21]Clayton A, Mason MD: Exosomes in tumour immunity. Curr Oncol 2009, 16:46-49.
• [22]Chivet M, Hemming F, Pernet-Gallay K, Fraboulet S, Sadoul R: Emerging role of neuronal exosomes in the central nervous system. Front Physiol 2012, 3:145.
• [23]Lachenal G, Pernet-Gallay K, Chivet M, Hemming FJ, Belly A, Bodon G, Blot B, Haase G, Goldberg Y, Sadoul R: Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci 2011, 46:409-418.
• [24]Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO: Blood–brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
• [25]Wisniewski JR, Zougman A, Nagaraj N, Mann M: Universal sample preparation method for proteome analysis. Nat Methods 2009, 6:359-362.
• [26]Hirosawa M, Hoshida M, Ishikawa M, Toya T: MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci 1993, 9:161-167.
• [27]Haqqani AS, Kelly JF, Stanimirovic DB: Quantitative protein profiling by mass spectrometry using label-free proteomics. Methods Mol Biol 2008, 439:241-256.
• [28]Haqqani AS, Caram-Salas N, Ding W, Brunette E, Delaney CE, Baumann E, Boileau E, Stanimirovic DB: Multiplexed evaluation of serum and CSF pharmacokinetics of brain-targeting single-domain antibodies using nanoLC-SRM-ILIS method. Mol Pharm 2012. In Press
• [29]Haqqani AS, Stanimirovic DB: Intercellular interactomics of human brain endothelial cells and th17 lymphocytes: a novel strategy for identifying therapeutic targets of CNS inflammation. Cardiovasc Psychiatry Neurol 2011, 2011:175364.
• [30]Yu LR, Conrads TP, Uo T, Kinoshita Y, Morrison RS, Lucas DA, Chan KC, Blonder J, Issaq HJ, Veenstra TD: Global analysis of the cortical neuron proteome. Mol Cell Proteomics 2004, 3:896-907.
• [31]Abulrob A, Sprong H, Van Bergen en HP, Stanimirovic D: The blood–brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. J Neurochem 2005, 95:1201-1214.
• [32]Muruganandam A, Tanha J, Narang S, Stanimirovic D: Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood–brain barrier endothelium. FASEB J 2002, 16:240-242.
• [33]Tanha J, Muruganandam A, Stanimirovic D: Phage display technology for identifying specific antigens on brain endothelial cells. Methods Mol Med 2003, 89:435-449.
• [34]Thery C, Zitvogel L, Amigorena S: Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
• [35]Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ: Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011, 29:341-345.
• [36]Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L, Miller D, Zhang HG: Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 2011, 19:1769-1779.
• [37]Jones AR, Shusta EV: Blood–brain barrier transport of therapeutics via receptor-mediation. Pharm Res 2007, 24:1759-1771.
• [38]Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R: A new function for the LDL receptor: transcytosis of LDL across the blood–brain barrier. J Cell Biol 1997, 138:877-889.
• [39]Demeule M, Poirier J, Jodoin J, Bertrand Y, Desrosiers RR, Dagenais C, Nguyen T, Lanthier J, Gabathuler R, Kennard M, Jefferies WA, Karkan D, Tsai S, Fenart L, Cecchelli R, Beliveau R: High transcytosis of melanotransferrin (P97) across the blood–brain barrier. J Neurochem 2002, 83:924-933.